These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23549356)
1. Syntheses and evaluation of macrocyclic engelhardione analogs as antitubercular and antibacterial agents. Shen L; Maddox MM; Adhikari S; Bruhn DF; Kumar M; Lee RE; Hurdle JG; Lee RE; Sun D J Antibiot (Tokyo); 2013 Jun; 66(6):319-25. PubMed ID: 23549356 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial evaluation of macrocyclic diarylheptanoid derivatives. Lin H; Bruhn DF; Maddox MM; Singh AP; Lee RE; Sun D Bioorg Med Chem Lett; 2016 Aug; 26(16):4070-6. PubMed ID: 27406794 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antituberculosis activity of the first macrocyclic glycoterpenoids comprising glucosamine and diterpenoid isosteviol. Garifullin BF; Strobykina IY; Sharipova RR; Kravchenko MA; Andreeva OV; Bazanova OB; Kataev VE Carbohydr Res; 2016 Aug; 431():15-24. PubMed ID: 27267064 [TBL] [Abstract][Full Text] [Related]
5. Antibacterial and antitubercular evaluation of dihydronaphthalenone-indole hybrid analogs. V PK; J R; C T FS; K T A; S Keri R; Varughese S; Balappa Somappa S Chem Biol Drug Des; 2017 Nov; 90(5):703-708. PubMed ID: 28374540 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antitubercular activity of substituted phenylmethyl- and pyridylmethyl amines. Tripathi RP; Saxena N; Tiwari VK; Verma SS; Chaturvedi V; Manju YK; Srivastva AK; Gaikwad A; Sinha S Bioorg Med Chem; 2006 Dec; 14(24):8186-96. PubMed ID: 17010617 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and anti-tuberculosis activity of glycitylamines. Corkran HM; Dangerfield EM; Haslett GW; Stocker BL; Timmer MS Bioorg Med Chem; 2016 Feb; 24(4):693-702. PubMed ID: 26810833 [TBL] [Abstract][Full Text] [Related]
8. Solid-Phase Synthesis and Antibacterial Activity of Cyclohexapeptide Wollamide B Analogs. Tsutsumi LS; Elmore JM; Dang UT; Wallace MJ; Marreddy R; Lee RB; Tan GT; Hurdle JG; Lee RE; Sun D ACS Comb Sci; 2018 Mar; 20(3):172-185. PubMed ID: 29431987 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, Antibacterial and Antitubercular Activities of Some 5H-Thiazolo[3,2-a]pyrimidin-5-ones and Sulfonic Acid Derivatives. Cai D; Zhang ZH; Chen Y; Yan XJ; Zou LJ; Wang YX; Liu XQ Molecules; 2015 Sep; 20(9):16419-34. PubMed ID: 26378507 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimicrobial evaluation of new nitric oxide-donating fluoroquinolone/oxime hybrids. Aziz HA; Moustafa GAI; Abuo-Rahma GEA; Rabea SM; Hauk G; Krishna VS; Sriram D; Berger JM; Abbas SH Arch Pharm (Weinheim); 2021 Jan; 354(1):e2000180. PubMed ID: 32959443 [TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and evaluation of oxime-functionalized nitrofuranylamides as novel antitubercular agents. Fan YL; Wu JB; Ke X; Huang ZP Bioorg Med Chem Lett; 2018 Oct; 28(18):3064-3066. PubMed ID: 30119957 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and mycobacterial evaluation of 5-substituted-6-acetyl-2-amino-7-methyl-5,8-dihydropyrido-[2,3-d]pyrimidin-4(3H)-one derivatives. Agre N; Degani M; Gupta A; Bhakta S; Ray MK Arch Pharm (Weinheim); 2019 Sep; 352(9):e1900068. PubMed ID: 31339194 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, antimycobacterial and antibacterial activity of 1-(6-amino-3,5-difluoropyridin-2-yl)fluoroquinolone derivatives containing an oxime functional moiety. Huang J; Wang M; Wang B; Wu Z; Liu M; Feng L; Zhang J; Li X; Yang Y; Lu Y Bioorg Med Chem Lett; 2016 May; 26(9):2262-7. PubMed ID: 27020299 [TBL] [Abstract][Full Text] [Related]
14. Physicochemical and biological characterization of novel macrocycles derived from o-phthalaldehyde. Reddy PM; Ho YP; Shanker K; Rohini R; Ravinder V Eur J Med Chem; 2009 Jun; 44(6):2621-5. PubMed ID: 18996622 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosis. Gatadi S; Gour J; Shukla M; Kaul G; Dasgupta A; Madhavi YV; Chopra S; Nanduri S Eur J Med Chem; 2019 Aug; 175():287-308. PubMed ID: 31096152 [TBL] [Abstract][Full Text] [Related]
16. Antitubercular Bis-Substituted Cyclam Derivatives: Structure-Activity Relationships and in Vivo Studies. Spain M; Wong JK; Nagalingam G; Batten JM; Hortle E; Oehlers SH; Jiang XF; Murage HE; Orford JT; Crisologo P; Triccas JA; Rutledge PJ; Todd MH J Med Chem; 2018 Apr; 61(8):3595-3608. PubMed ID: 29558124 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, structural, multitargeted molecular docking analysis of anti-cancer, anti-tubercular, DNA interactions of benzotriazole based macrocyclic ligand. Pon Matheswari P; Ilavarasi Jeyamalar J; Iruthayaraj A; Ravindran Durai Nayagam B Bioorg Chem; 2024 Jun; 147():107361. PubMed ID: 38613924 [TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship of truncated analogs of caprazamycins as potential anti-tuberculosis agents. Hirano S; Ichikawa S; Matsuda A Bioorg Med Chem; 2008 May; 16(9):5123-33. PubMed ID: 18375127 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and antituberculosis activity of novel unfolded and macrocyclic derivatives of ent-kaurane steviol. Khaybullin RN; Strobykina IY; Dobrynin AB; Gubaydullin AT; Chestnova RV; Babaev VM; Kataev VE Bioorg Med Chem Lett; 2012 Nov; 22(22):6909-13. PubMed ID: 23046964 [TBL] [Abstract][Full Text] [Related]
20. Synthesis of new sugar derivatives and evaluation of their antibacterial activities against Mycobacterium tuberculosis. Horita Y; Takii T; Chiba T; Kuroishi R; Maeda Y; Kurono Y; Inagaki E; Nishimura K; Yamamoto Y; Abe C; Mori M; Onozaki K Bioorg Med Chem Lett; 2009 Nov; 19(22):6313-6. PubMed ID: 19828313 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]